Form 4 · Filed Jul 9, 2026, 09:19 PM UTC
HALO/HALOZYME THERAPEUTICS, INC.
Torley Helen — PRESIDENT AND CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | M | other | 1,923 | $12 | $23,211 | 769,703 |
| Jul 8, 2026 | S | sell | 888 | $79 | $70,397 | 768,815 |
| Jul 8, 2026 | S | sell | 1,035 | $80 | $82,994 | 767,780 |
| Jul 8, 2026 | M | other | 1,923 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001159036-26-000100